(MedPage Today) — Sen. Ron Johnson (R-Wisc.) said Tuesday he would begin an investigation into the FDA’s handling of approval applications for biologic therapies to treat Duchenne muscular dystrophy (DMD) and other rare life-threatening disorders…
Source link
Ad Banner
Show Comments (0)
Hide Comments (0)
Subscribe
Login
0 Comments
Oldest
